Use of Thiazolidinediones and Fracture Risk

Archives of Internal Medicine
doi 10.1001/archinte.168.8.820
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Effect of Thiazolidinediones on Insulin Resistance and Cardiovascular Risk Factors

Obesity and Metabolism
Internal MedicineNutritionEndocrinologyPublic HealthEnvironmentalDieteticsOccupational HealthMetabolismDiabetes
2008English

Use of Thiazolidinediones and the Risk of Elective Hip or Knee Replacement: A Population Based Case-Control Study

British Journal of Clinical Pharmacology
Pharmacology
2015English

Polycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction?

Diabetes Spectrum
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Use of Anti-Depressants and the Risk of Fracture of the Hip or Femur

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2009English

Use of Anti-Depressants and the Risk of Fracture of the Hip or Femur

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2009English

Physical Activity and Risk of Fracture

Journal of Osteoporosis and Physical Activity
2014English

Letter: Association Between Proton Pump Inhibitor Use and Fracture Risk - Causality or Confounding?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Chemotherapy and Chemoprevention by Thiazolidinediones

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy